Global. Reckitt Benckiser is interested in acquiring over-the-counter business of American Pfizer, although the acquisition of Mead Johnson at the beginning of 2017 casts doubt on the company's ability to implement another major transaction.World: British company Reckitt Benckiser is interested in acquiring over-the-counter business of American Pfizer 115 words 17 October 2017 Daily news of the chemical enterprises of the CIS CHMDN Russian Business World Agency, 2017 British company Reckitt Benckiser intends to consider financing options for a purchase of OTC business of American Pfizer, which will be put up for sale in 2018, informed sources said. Including do not exclude the issuance of shares of several billion pounds sterling, the exchange of assets or the purchase of individual assets of the American company. According to sources, the acquisition of Mead Johnson for 13.2 billion pounds at the beginning of this year casts doubt on the company's ability to implement another major transaction. Analysts warn that Reckitt Benckiser will enlist the support of shareholders on the deal with Pfizer, because as a result of the transaction the amount of the debt of the British company will be 4 times higher than its profit. (pharmvestnik.ru / Chemistry of Ukraine and the World)http://hogar.intelect.com.mx/notes/global-reckitt-benckiser-is-interested-in-acquiring-over-the-counter-business-of-american-pfizer-despite-that-the-acquisition-of-mead-johnson-at-the-beginning-of-2017-casts-doubt-on-the-companys-ability-to-implement-another-major-transactionhttp://hogar.intelect.com.mx/@@site-logo/logoAllen.png
Global. Reckitt Benckiser is interested in acquiring over-the-counter business of American Pfizer, although the acquisition of Mead Johnson at the beginning of 2017 casts doubt on the company's ability to implement another major transaction.
World: British company Reckitt Benckiser is interested in acquiring over-the-counter business of American Pfizer 115 words 17 October 2017 Daily news of the chemical enterprises of the CIS CHMDN Russian Business World Agency, 2017 British company Reckitt Benckiser intends to consider financing options for a purchase of OTC business of American Pfizer, which will be put up for sale in 2018, informed sources said. Including do not exclude the issuance of shares of several billion pounds sterling, the exchange of assets or the purchase of individual assets of the American company. According to sources, the acquisition of Mead Johnson for 13.2 billion pounds at the beginning of this year casts doubt on the company's ability to implement another major transaction. Analysts warn that Reckitt Benckiser will enlist the support of shareholders on the deal with Pfizer, because as a result of the transaction the amount of the debt of the British company will be 4 times higher than its profit. (pharmvestnik.ru / Chemistry of Ukraine and the World)
World: British company Reckitt Benckiser is interested in acquiring over-the-counter business of American Pfizer
115 words 17 October 2017 Daily news of the chemical enterprises of the CIS CHMDN Russian Business World Agency, 2017
British company Reckitt Benckiser intends to consider financing options for a purchase of OTC business of American Pfizer, which will be put up for sale in 2018, informed sources said. Including do not exclude the issuance of shares of several billion pounds sterling, the exchange of assets or the purchase of individual assets of the American company.
According to sources, the acquisition of Mead Johnson for 13.2 billion pounds at the beginning of this year casts doubt on the company's ability to implement another major transaction. Analysts warn that Reckitt Benckiser will enlist the support of shareholders on the deal with Pfizer, because as a result of the transaction the amount of the debt of the British company will be 4 times higher than its profit. (pharmvestnik.ru / Chemistry of Ukraine and the World)
